CT
VERA icon

Cambridge Trust’s Vera Therapeutics VERA Stock Holding History

Cambridge Trust’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.07M Buy
48,107
+38,220
+387% +$1.36M 0.08% 116
2023
Q4 		$152K Hold
9,887
– – 0.01% 298
2023
Q3 		$136K Hold
9,887
– – 0.01% 312
2023
Q2 		$159K Hold
9,887
– – 0.01% 295
2023
Q1 		$76.7K Hold
9,887
– – ﹤0.01% 389
2022
Q4 		$191K Hold
9,887
– – 0.01% 294
2022
Q3 		$211K Hold
9,887
– – 0.01% 265
2022
Q2 		$135K Hold
9,887
– – 0.01% 354
2022
Q1 		$232K Hold
9,887
– – 0.01% 317
2021
Q4 		$264K Buy
+9,887
New +$219K 0.01% 299

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambridge Trust's VERA Position: Q1 2024 in Review

Cambridge Trust increased its Vera Therapeutics (VERA) stake by 387% in Q1 2024, buying an estimated $1.36M and bringing the position to 48,107 shares worth $2.07M. The position accounts for 0.08% of the portfolio, ranked #116.

Cambridge Trust first reported a position in VERA in Q4 2021 and has held it in 10 quarters since. 160 funds tracked by Wall St. Rank hold VERA as of Q1 2024.

  • Cambridge Trust held 48,107 shares of Vera Therapeutics worth $2.07M as of Q1 2024.
  • Cambridge Trust bought 38,220 Vera Therapeutics shares in Q1 2024, an estimated $1.36M.
  • Vera Therapeutics made up 0.08% of Cambridge Trust's portfolio in Q1 2024, its #116 holding.
  • Cambridge Trust first reported a position in Vera Therapeutics in Q4 2021 and has held it in 10 quarters since.
  • 160 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.